Since diabetes is becoming more common in India, it is essential to seek into better, more cost-effective, and safe anti-diabetic treatment options. We have introduced sitagliptin under two of our brands, Glipcose and Sitglypt, with strengths of 25, 50, and 100 mg as part of our mission of Making Lives Healthier. Furthermore, Glipcose M and Sitglypt M contain Sitagliptin 50 mg and Metformin 500/1000 mg. These brands are made utilising DMF Grade APIs in a USFDA-registered manufacturing facility. Anti-diabetic medications Sitglypt and Glipcose are efficient and affordable.
